Guardian Operating Income from 2010 to 2026
| GRDN Stock | 33.54 0.50 1.51% |
Operating Income | First Reported 2018-12-31 | Previous Quarter 12.6 M | Current Value 16.4 M | Quarterly Volatility 25.3 M |
Check Guardian Pharmacy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardian Pharmacy's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.4 M, Interest Expense of 2.5 M or Selling And Marketing Expenses of 3 M, as well as many indicators such as Price To Sales Ratio of 1.35, Dividend Yield of 0.022 or PTB Ratio of 9.62. Guardian financial statements analysis is a perfect complement when working with Guardian Pharmacy Valuation or Volatility modules.
Guardian | Operating Income | Build AI portfolio with Guardian Stock |
Evaluating Guardian Pharmacy's Operating Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Guardian Pharmacy Services's fundamental strength.
Latest Guardian Pharmacy's Operating Income Growth Pattern
Below is the plot of the Operating Income of Guardian Pharmacy Services over the last few years. Operating Income is the amount of profit realized from Guardian Pharmacy operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Guardian Pharmacy Services is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Guardian Pharmacy's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Guardian Pharmacy's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Guardian Operating Income Regression Statistics
| Arithmetic Mean | 14,663,729 | |
| Coefficient Of Variation | 240.72 | |
| Mean Deviation | 25,568,916 | |
| Median | 25,931,000 | |
| Standard Deviation | 35,298,244 | |
| Sample Variance | 1246T | |
| Range | 114.9M | |
| R-Value | (0.54) | |
| Mean Square Error | 943.3T | |
| R-Squared | 0.29 | |
| Significance | 0.03 | |
| Slope | (3,765,779) | |
| Total Sum of Squares | 19935.5T |
Guardian Operating Income History
About Guardian Pharmacy Financial Statements
Guardian Pharmacy investors utilize fundamental indicators, such as Operating Income, to predict how Guardian Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | -56.6 M | -53.8 M |
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving together with Guardian Stock
Moving against Guardian Stock
| 0.77 | DTCK | Davis Commodities | PairCorr |
| 0.7 | 3GX | HF FOODS GRP | PairCorr |
| 0.51 | HITI | High Tide | PairCorr |
| 0.38 | MRU | Metro Inc | PairCorr |
| 0.36 | GO | Grocery Outlet Holding | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Guardian Pharmacy Correlation against competitors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Will Consumer Staples Distribution & Retail sector continue expanding? Could Guardian diversify its offerings? Factors like these will boost the valuation of Guardian Pharmacy. Market participants price Guardian higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Guardian Pharmacy data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.2 | Return On Assets | Return On Equity |
Understanding Guardian Pharmacy requires distinguishing between market price and book value, where the latter reflects Guardian's accounting equity. The concept of intrinsic value - what Guardian Pharmacy's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Guardian Pharmacy's price substantially above or below its fundamental value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Guardian Pharmacy's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.